Edition:
United Kingdom

Menlo Therapeutics Inc (MNLO.OQ)

MNLO.OQ on NASDAQ Stock Exchange Global Select Market

5.57USD
18 Jan 2019
Change (% chg)

$0.05 (+0.91%)
Prev Close
$5.52
Open
$5.53
Day's High
$5.66
Day's Low
$5.50
Volume
15,281
Avg. Vol
43,009
52-wk High
$38.68
52-wk Low
$3.74

Chart for

About

Menlo Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions, such as atopic dermatitis, psoriasis and prurigo nodularis. It is also evaluating the use of serlopitant for the... (more)

Overall

No Ratios Available.

Financials

  MNLO.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -- -- --
ROI: -- 8.99 14.48
ROE: -- 10.13 15.99

Earnings vs. Estimates